DALLAS — Treatment modality for HPV-positive oropharyngeal squamous cell carcinoma varied considerably by facility type, according to study results. The findings — presented at American Head & Neck ...
Background. Data on the relative carcinogenic potential of human papillomavirus (HPV) types among women infected with human immunodeficiency virus (HIV) (WHIV) are needed to inform prevention programs ...
November 6, 2008 — Human papillomavirus (HPV) infection has recently been established as an important risk factor for oropharyngeal cancers. Using a noninvasive oral rinse, researchers have now ...
PRINCETON, N.J., June 02, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the ...
If a person receives a positive human papillomavirus (HPV) result from a Pap smear, they need a colposcopy to confirm the diagnosis. This is a minimally invasive procedure that healthcare ...
Although most of us will be exposed human papillomavirus (HPV) at some point in our lives, it remains widely misunderstood.Receiving a positive HPV result can be worrying and confusing, yet the link ...
Faced with a positive human papillomavirus (HPV) test, patients are quickly overwhelmed by anxiety-inducing questions. It is crucial to provide them with adequate responses to reassure them, ...
PDS0101, an innovative immunotherapy, targets HPV-positive cancers, including recurrent or metastatic head and neck cancer with high-risk HPV16 infection. VERSATILE-002 Phase 2 clinical trial ...
Women aged 24-45 years not already infected with the human papilloma virus (HPV) can be protected by the HPV vaccine, concludes an Article published Online First and in an upcoming edition of The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback